Average Bioavailability Assessment
Average Bioavailability Assessment is a statistical method used in bioequivalence studies to quantify the relative systemic exposure of a drug formulation by comparing the mean area under the plasma concentration-time curve (AUC) and maximum concentration (Cmax) between test and reference products under standardized conditions.
16
Publications
3.2K
Citations
45
Authors
23
Institutions
Publications per year
2017–2026
1
16
On population and individual bioequivalence
Robert Schall, H. G. Luus · Statistics in Medicine · 1993 · 184 citations
Moment-based criteria for determining bioequivalence
Daniel Holder, Francis Hsuan · Biometrika · 1993 · 57 citations
1–5 of 16
45
2
h-index
United States Food and Drug Administration, United States
2 publications · 2.6K citations
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 45
23
Orion Corporation (Finland)
Espoo, Finland
2 h-index
3 publications
47 citations
Wright State University
Dayton, United States
1 h-index
1 publications
19 citations
Orion Corporation (United Kingdom)
Reading, United Kingdom
1 h-index
1 publications
11 citations
Klinikum Konstanz
Konstanz, Germany
1 h-index
2 publications
86 citations
Zimmer Biomet (Germany)
Berlin, Germany
1 h-index
2 publications
86 citations

Thomas Jefferson University
Philadelphia, United States
1 h-index
1 publications
25 citations

Hoshi University
Tokyo, Japan
1 h-index
6 publications
78 citations
Institute of Vegetables and Flowers
Beijing, China
1 h-index
1 publications
34 citations
1–8 of 23
4 publications · 246 citations
4
h-index
2 publications · 108 citations
2
h-index
1 publications · 13 citations
1
h-index
Repository · 1 publications · 25 citations
1
h-index
1 publications · 19 citations
1
h-index
1–5